Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1934 1
1945 2
1946 3
1948 2
1949 1
1950 2
1951 2
1952 3
1953 7
1954 9
1955 8
1956 7
1957 17
1958 4
1960 2
1961 6
1962 10
1963 11
1964 7
1965 14
1966 10
1967 5
1968 15
1969 13
1970 11
1971 14
1972 24
1973 17
1974 17
1975 23
1976 25
1977 20
1978 19
1979 29
1980 20
1981 15
1982 15
1983 10
1984 20
1985 17
1986 15
1987 15
1988 24
1989 17
1990 22
1991 15
1992 32
1993 24
1994 26
1995 21
1996 33
1997 20
1998 26
1999 22
2000 32
2001 21
2002 25
2003 31
2004 30
2005 43
2006 38
2007 38
2008 34
2009 38
2010 36
2011 31
2012 37
2013 37
2014 27
2015 19
2016 9
2017 19
2018 11
2019 10
2020 10
2021 10
2022 7
2023 2
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,330 results

Results by year

Filters applied: . Clear all
Page 1
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. Among authors: schumacher h. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ. Neogi T, et al. Among authors: schumacher hr. Ann Rheum Dis. 2015 Oct;74(10):1789-98. doi: 10.1136/annrheumdis-2015-208237. Ann Rheum Dis. 2015. PMID: 26359487 Free PMC article.
2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ. Neogi T, et al. Among authors: schumacher hr. Arthritis Rheumatol. 2015 Oct;67(10):2557-68. doi: 10.1002/art.39254. Arthritis Rheumatol. 2015. PMID: 26352873 Free PMC article.
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N. Becker MA, et al. Among authors: schumacher hr jr. N Engl J Med. 2005 Dec 8;353(23):2450-61. doi: 10.1056/NEJMoa050373. N Engl J Med. 2005. PMID: 16339094 Free article. Clinical Trial.
Haemochromatosis.
Schumacher HR Jr. Schumacher HR Jr. Baillieres Best Pract Res Clin Rheumatol. 2000 Jun;14(2):277-84. doi: 10.1053/berh.2000.0065. Baillieres Best Pract Res Clin Rheumatol. 2000. PMID: 10925745 Free article. Review.
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.
Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R; American College of Rheumatology. Khanna D, et al. Among authors: schumacher hr. Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46. doi: 10.1002/acr.21772. Arthritis Care Res (Hoboken). 2012. PMID: 23024028 Free PMC article. No abstract available.
Parathyroid disease.
Wen HY, Schumacher HR Jr, Zhang LY. Wen HY, et al. Among authors: schumacher hr jr. Rheum Dis Clin North Am. 2010 Nov;36(4):647-64. doi: 10.1016/j.rdc.2010.09.002. Rheum Dis Clin North Am. 2010. PMID: 21092844 Review.
Acute monoarthritis.
Baker DG, Schumacher HR Jr. Baker DG, et al. Among authors: schumacher hr jr. N Engl J Med. 1993 Sep 30;329(14):1013-20. doi: 10.1056/NEJM199309303291407. N Engl J Med. 1993. PMID: 8366902 Review. No abstract available.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Among authors: schumacher h. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
1,330 results